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Abstract
 
To assess the role of lymphotoxin-
 
 
 
 receptor (LT
 
 
 
R) in diabetes pathogenesis, we expressed an
LT
 
 
 
R–Fc fusion protein in nonobese diabetic (NOD) mice. The fusion protein was expressed
in the embryo, reached high levels for the first 2 wk after birth, and then declined progressively
with age. High expression of LT
 
 
 
R–Fc blocked diabetes development but not insulitis. After
the decline in chimeric protein concentration, mice became diabetic with kinetics similar to the
controls. Early expression of fusion protein resulted in disrupted splenic architecture. However,
primary follicles and follicular dendritic cells, but not marginal zones, developed in aged mice.
Hence, LT
 
 
 
R signaling is required for diabetes development and regulates follicular and mar-
ginal zone structures via qualitatively or quantitatively distinct mechanisms.
Key words: autoimmune disease • tumor necrosis factor • LIGHT • lymphoid development • 
marginal zone
 
Introduction
 
The lymphotoxin-
 
 
 
 receptor (LT
 
 
 
R) is a member of the
TNF receptor family and is required for normal develop-
ment of the secondary lymphoid system (1). To date, there
are two known cytokines capable of signaling through
LT
 
 
 
R. The first is lymphotoxin-
 
 
 
 (LT
 
 
 
), a cell-bound
heterotrimeric complex, whose genes, LT
 
 
 
 and LT
 
 
 
(along with TNF), are clustered within the MHC gene
complex (2). The second cytokine, LIGHT, is a mem-
brane-anchored homotrimeric complex, capable of binding
LT
 
 
 
R, and an orphan member of the TNF receptor fam-
ily, herpes simplex virus entry mediator (3–5).
Blockade of LT
 
 
 
R signaling through selective gene tar-
geting or neutralizing fusion protein results in loss of lymph
nodes and Peyer’s patches (6–8). Moreover, these mice ex-
hibit disrupted splenic architecture, lacking marginal zones,
primary follicles, follicular dendritic cells (FDCs), and ger-
minal centers (1). The role of LT
 
 
 
R signaling in autoim-
mune processes has been difficult to evaluate due to the
lack of major lymphoid organ development in LT
 
 
 
R-,
LT
 
 
 
-,
 
 
 
and LT
 
 
 
-deficient mice.
To address this issue, we backcrossed mice that express a
neutralizing LT
 
 
 
R–Fc chimeric protein onto the non-
obese diabetic (NOD) background. Like mice deficient in
LT
 
 
 
R expression, these mice display disrupted splenic ar-
chitecture (7, 9). However, most lymph nodes develop
normally (10). These animals provide an important oppor-
tunity to study the role of LT
 
 
 
R signaling in diabetes de-
velopment in an intact lymphoid environment. Here we
report that LT
 
 
 
R signaling is a critical element in type 1
diabetes mellitus and that temporal variation in expression
of the LT
 
 
 
R–Fc fusion protein reveals novel aspects of B
cell localization and migration.
 
Materials and Methods
 
Mice.
 
All mice were maintained and bred at Stanford Univer-
sity Animal Facility under barrier isolation conditions. BALB/c
 
mice expressing a soluble murine LT
 
 
 
R–Fc fusion protein have
previously been described (9, 10). Transgene-positive male mice
were bred for seven generations to female NOD mice obtained
from the Stanford/McD NOD colony. These mice were then
bred for two to six additional generations to NOD.Lt mice ob-
tained directly from The Jackson Laboratory. Mice containing the
integrated transgene were identified by PCR analysis, and soluble
chimeric protein in the serum was quantified by immunoassay as
described previously (10).
 
Detection of T Cells Autoreactive to Islet Cell Antigens.
 
10
 
6
 
 spleno-
cytes per well of 11-wk-old female transgene-positive and litter-
mate control NOD mice were cultured in 96-well dishes in
RPMI medium containing 0.5% Neutridoma-SP (Boehringer
Mannheim) and 0.5% autologous NOD serum with 10 
 
 
 
g/ml of
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purified recombinant murine glutamic acid decarboxylase 65
(GAD) (11). Response to GAD was detected with [
 
3
 
H]thymidine
incorporation and cytokine production after 72 h.
Production of IFN-
 
 
 
 was detected by immunoassay. 96-well
plates were coated with rat anti–mouse IFN-
 
 
 
 antibodies
(PharMingen). Dilutions of supernatant or control cytokine were
detected with biotin-conjugated anti–mouse IFN-
 
 
 
 (PharMin-
gen) and streptavidin (SA)-conjugated europium (Wallac).
 
Assessment of Insulitis, Sialitis, and Diabetes.
 
Insulitis and sialitis
were determined from hematoxylin and eosin–stained pancreas
and salivary gland tissue from mice 11–52 wk of age. The severity
of insulitis was scored in blinded fashion from pancreata isolated
from 11–13- and 17–19-wk-old female LT
 
 
 
R–Fc-expressing
NOD mice or littermate controls: intact islets, no infiltrating
cells; periinsulitis, 
 
 
 
50% islets infiltrated with intact 
 
 
 
 cells; insu-
litis, 
 
 
 
50% islets infiltrated with sparse 
 
 
 
 cell damage; and de-
structive insulitis, 
 
 
 
50% islets infiltrated with few intact 
 
 
 
 cells
present. Mouse urine glucose levels were measured weekly using
Chemstrips (Boehringer Mannheim), and mice were considered
diabetic on the first of three consecutive weeks of glycosuria.
 
Immunohistology.
 
Spleen, pancreas, lymph nodes (axillary,
brachial, inguinal, popliteal, and pancreatic), and salivary glands
from female NOD transgene-positive and littermate control mice
were formalin fixed and stained with hematoxylin and eosin. Ac-
etone-fixed frozen lymphoid tissue was stained with biotinylated
CD3 (PharMingen), biotinylated CD11c, biotinylated MECA-
367, biotinylated CR-1 antibodies, biotinylated peanut aggluti-
nin (PNA) (Vector Laboratories), or rat antibodies specific for
IgD (1126C) or FDC (FDC-M2). Bound antibodies were de-
tected with a combination of the following: SA-conjugated Al-
exa-350 (blue; Molecular Probes), SA-conjugated Oregon Green
(green; Molecular Probes), Neutralite–avidin-conjugated Texas
Red (red; Southern Biotechnology), and goat anti–rat Oregon
Green. IgM was detected with goat anti–mouse IgM–Texas Red
(red; Southern Biotechnology), and CD8 (53.6.7) was detected
with directly conjugated Alexa-350 antibody (blue).
 
Flow Cytometry.
 
Splenocytes were stained with mAbs specific
for T cell, B cell, and macrophage surface antigens as described
previously (9).
 
Results and Discussion
 
The LT
 
 
 
R–Fc Fusion Protein Is Expressed Transiently on
the NOD Background.
 
To determine the role of LT
 
 
 
R
signaling in diabetes development, mice expressing a neu-
tralizing LT
 
 
 
R–human IgG1 (LT
 
 
 
R–Fc) fusion protein
under control of the human CMV promoter (9, 10) were
bred onto the NOD background. Two independently gen-
erated lines of mice were established. Line 1610 expressed
high concentrations of LT
 
 
 
R–Fc (“high expressers”; 0.8–
30 
 
 
 
g/ml [mean 4] at 5–10 wk of age), while line 201 ex-
pressed low levels of this molecule (“low expressers”; 0.38–
1.1 
 
 
 
g/ml [mean 0.6] at 5–10 wk of age).
To assess onset of transgene expression, 1610 NOD male
mice were mated to NOD females. Serum was collected
on multiple days before and after birth and analyzed for
LT
 
 
 
R–Fc protein. As shown in Fig. 1, the transgene was
expressed at high levels (2.3–3.9 
 
 
 
g/ml) on or before
E16.5. Moreover, significant concentrations of fusion pro-
tein were also observed in transgene-negative littermates
(
 
 
 
2 
 
 
 
g/ml), and low amounts were detected in transgene-
negative mothers (
 
 
 
0.5 
 
 
 
g/ml). In transgene-negative
mice, serum fusion protein concentration declined to insig-
nificant levels by 14 d of age, while transgene-positive mice
expressed very high levels at this age (7–18 
 
 
 
g/ml). Inter-
estingly, the LT
 
 
 
R–Fc serum concentration from trans-
gene-positive NOD mice was 3–10 times higher than
those observed in BALB/c mice (data not shown).
Although the Fc portion of the human IgG1 was mu-
tated to inhibit Fc binding and complement fixation, the
region required for placental transfer was not affected (12).
Thus, the fusion protein presumably crossed the placenta
from the transgene-positive fetus to the mother and hence
into the transgene-negative littermates.
Serial blood samples were collected from single mice and
individual litters to determine LT
 
 
 
R–Fc levels over many
months. We were surprised to find that while the fusion
protein was expressed at very high concentrations in the
first few weeks of life, these levels declined with age. By 22
wk, circulating fusion protein concentrations in all NOD
mice tested were reduced by as much as 90% (Table I; see
Fig. 4 C). It is of interest that expression of the same trans-
gene on the BALB/c background did not decrease with
age (data not shown).
Declining expression of the fusion protein may reflect
the availability of transcription factors able to bind the
CMV promoter or epigenetic modifications such as differ-
ential methylation patterns. This modulated expression of
the chimeric fusion protein provides a unique opportunity
to explore the relationship between LT
 
 
 
R signaling, lym-
phoid architecture, and diabetes development.
 
Early LT
 
 
 
R Blockade Results in Sustained Arrest of Marginal
Zone Cell Development.
 
Given the declining expression of
blocking fusion protein, we examined lymphoid tissue
from NOD mice at multiple ages. Phenotypic characteriza-
Figure 1. Both transgene-negative and -positive embryonic mice con-
tain circulating LT R–Fc fusion protein. The concentration of soluble
LT R–Fc chimeric protein was determined from embryos at E16.5,
E18.5, and E19.5, neonates at 4, 7, and 14 d of age, and from their trans-
gene-negative mothers (black bars*) that were bred to male 1610 NOD
mice. NOD negative control serum determined baseline levels (first bar).
Transgene-negative (black bars) and transgene-positive mice (gray bars)
were identified by PCR analysis. 
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tion determined by flow cytometry revealed no significant
differences between LT
 
 
 
R–Fc-expressing mice and litter-
mate controls with respect to percentages of cells that ex-
press follicular B cell (Table I) and T cell and macrophage
(data not shown) surface antigens. However, marginal zone
B cell populations were significantly reduced in both NOD
line 201 and 1610 as determined by CD21
 
high
 
CD23
 
low/neg
 
expression (Table I). By immunohistological analysis, it was
determined that spleens isolated from 11–13-wk-old “high
expressing” 1610 mice developed poorly defined primary
follicles, FDC networks, and marginal zones (compare pan-
els A and D with B and E in Fig. 2) and had diminished or
no expression of MOMA-1 on marginal zone metallophilic
macrophages or ER-TR9 on marginal zone macrophages
(data not shown) or marginal zone B cells (Table I), and no
mucosal addressin cell adhesion molecule (MAdCAM)-1
on marginal sinus (compare Fig. 2, C and I) was observed
in aged mice. However, the extent of splenic disruption
from mouse to mouse (and within the same spleen) varied,
with occasional secondary follicles containing FDC and
germinal centers observed in young 1610 NOD mice.
As circulating levels of fusion protein declined with age,
normalization of splenic architecture was observed. As early
as 17 wk of age, splenic primary follicles and FDC net-
works were present (Fig. 2, C and F). However, this re-
duction of LT
 
 
 
R–Fc levels did not lead to well defined
marginal zone development (as determined up to 31 wk of
age). Few MOMA-1
 
 
 
 or ER-TR9
 
 
 
 marginal zone metal-
lophilic macrophages (data not shown) or marginal zone B
cells (Table I), and no MAdCAM-1 (Fig. 2, C and I) was
observed in aged mice. As shown in Fig. 2 C, although
IgM
 
 
 
IgD
 
  
 
follicular B cells (yellow) formed polarized folli-
cles, few IgM
 
high
 
IgD
 
  
 
marginal zone B cells (red) were ob-
served beyond the B cell follicle boundary in aged trans-
gene-positive mice. Although conventional marginal zone
structures were absent or greatly reduced in aged high ex-
pressing 1610 mice, some B cells did appear to reside in the
marginal zone areas. These data suggest that “follicular” B
cell populations localized to the marginal zone area but did
not express the marginal zone B cell phenotype.
The events that control B cell compartmentalization
may require less LT
 
 
 
R engagement than required for mar-
ginal zone cell development. Notably, mouse line 201
does not express sufficient concentrations (at any time) to
affect primary follicles and FDC networks. However, mar-
ginal zones are reduced in these mice (Table I). This result
suggests that LT
 
 
 
R differentially controls follicle/FDC
formation and marginal zone development. The low levels
of circulating LT
 
 
 
R–Fc fusion protein in aged high ex-
pressing 1610 mice may be sufficient to allow for B cell
polarization and FDC development but not for marginal
zone formation.
 
Draining Pancreatic Lymph Nodes Develop Germinal Cen-
ters.
 
Due to early expression of fusion protein in both
transgene-positive and -negative neonates, we evaluated
lymph node development in adult mice. Only 1/16 high
expressing 1610 mice and 7/11 transgene-negative mice
possessed inguinal lymph nodes. Popliteal lymph nodes
were not present in any of seven transgene-positive mice
and were found in two of four transgene-negative mice, as
determined with India ink. However, six of six transgene-
negative mice and six of eight transgene-positive mice con-
tained at least one draining popliteal and inguinal lymph
node after footpad immunization. The draining lymph
nodes contained secondary follicles, FDC networks, and
germinal centers (data not shown). These data suggest that
poorly developed, small popliteal and inguinal lymph nodes
are present and can recruit lymphocytes after immunization.
 
Table I.
 
Early LT
 
 
 
R Blockade Inhibits Marginal Zone B
Cell Development
 
Mouse Age LT
 
 
 
R–Fc
 
*
 
MZB
 
‡§
 
FOB
 
‡§
 
wk
 
 
 
g/ml % %
 
Line 201
33 25 – 5.3 22.4
46 30 – 4.1 24.1
(4.7) (23.25)
30 25 0.2 1.2 24.6
42 30 0.2 1.9 21.1
44 30 0.1 2.9 32.6
(2.0 
 
 
 
 0.9) (26.1 
 
 
 
 5.9)
Line 1610
70 11 – 4.5 23.2
71 11 – 3.8 24.2
73 11 – 3.9 25.6
95 11 – 3.9 26.5
(4.0 
 
 
 
 0.3)
 
 
 
(24.9 
 
 
 
 1.5)
69 11 2.8 1.4 23.5
72 11 7.1 0.6 23.9
94 11 2.8 0.8 22.1
96 11 1.4 1.75 26.8
(1.1 
 
 
 
 0.5)
 
 
 
(24.1 
 
 
 
 2.0)
6 26 – 8.5 24.0
22 26 – 5.3 27.7
82 31 – 7.2 25.2
(7.0   1.6)¶ (25.6   1.9)
15 26 0.8 0.4 35.1
21 26 0.6 1.1 28.3
76 31 0.5 1.6 38.6
(1.0   0.6)¶ (34.0   5.2)
*Line 201 at 10 wk of age expressed: #30, ND; #42, 1.1; and #44,
0.85  g/ml. Line 1610 at 5 wk of age expressed: #15, 30.0; #21, 13.1,
and #76, 4.6  g/ml.
‡Percentage of CD21 CD23  marginal zone B cells (MZB) and
CD21lowCD23  follicular B cells (FOB) was determined by flow cy-
tometry.
§Mean   SD of each group is shown in parentheses.
 P   0.001 for differences of means in 11-wk-old transgene-positive
and -negative mice.
¶P   0.004 for differences of means in 26–31-wk-old transgene-posi-
tive and -negative mice.1336 A Critical Role for Lymphotoxin-  Receptor in Experimental Diabetes
Recently, it has been reported that draining pancreatic
lymph nodes are an important site where autoreactive T
cells first encounter self-antigen on APCs and become acti-
vated (13). Thus, it was important to determine if draining
pancreatic lymph nodes were present in LT R–Fc-
expressing mice. As shown in Fig. 2, mice expressing high
concentrations of fusion protein did not develop well de-
fined splenic primary follicles or FDC networks. However,
all 14 high expressing LT R–Fc 1610 mice examined
contained draining pancreatic lymph nodes. These pancre-
atic lymph nodes contained PNA  and CR-1  germinal
centers in B cell follicles (compare panels J and L to K and
M in Fig. 2). In addition, axillary, brachial, mesenteric, fa-
cial, and sub-aortic lymph nodes were all present and ap-
peared normal with regard to primary follicles, FDCs, T
cell areas, and dendritic cells (data not shown). These ex-
periments suggest that once these structures are formed,
LT R engagement regulates lymphocyte migration within
the splenic white pulp, but not lymph nodes. Although the
splenic microenvironment was disrupted in 11-wk-old
NOD mice, lymphocytes migrated properly within most
peripheral lymph nodes.
Figure 2. Formation of pri-
mary follicles and FDCs, but not
marginal zones, after a decline of
LT R–Fc in aged mice. Spleens
were removed from either 11-
wk-old (B, E, H) or 26-wk-old
(C, F, I) female NOD mice that
expressed the LT R–Fc (line
1610) fusion protein or 11-wk-
old littermate controls (A, D, G).
Frozen tissue sections were
stained for: (A–C) B cells (red,
IgM; green, IgD) and T cells
(blue, CD8); (D–F) B cells (red,
IgM), FDCs (green, CR-1), and
T cells (blue, CD8); (G–I) B cells
(red, IgM), MAdCAM-1 (green,
MECA367), and T cells (blue,
CD3) (original magnification
 100). Yellow color indicates
red and green colocalized. Cir-
culating fusion protein concen-
trations at time of sacrifice in
11-wk-old mice (B, E, H) were
between 1.4 and 7.1  g/ml
(mean 3.4) and in 26-wk-old
mice (C, F, I) were 0.5–0.8  g/ml
(mean 0.63). In the latter group,
LT R–Fc levels at 11 wk of age
were 4.4–21.8  g/ml (mean
11.5). Draining pancreatic lymph
nodes from either 12-wk-old
transgene-negative NOD mice (J
and L) or transgene-positive lit-
termates (K and M) were stained
for: (J–K) B cells (red, IgM), ger-
minal centers (green, PNA), and
T cells (blue, CD8); (L–M) B
cells (red, IgM), FDCs (green,
CR-1), and T cells (blue, CD3).
The concentration of fusion pro-
tein at time they were killed
(mouse #6, 7, 8, and 14) is de-
scribed in Fig. 4, D and E. Pan-
creata from 11-wk-old high ex-
pressing (line 1610) LT R–Fc
female NOD mice (O) or female
transgene-negative littermates
(N) were stained with hematox-
ylin and eosin. The data is repre-
sentative of numerous mice ex-
amined (original magnification
 250). Circulating fusion pro-
tein concentrations at time of
sacrifice was 2.8  g/ml.1337 Ettinger et al. Brief Definitive Report
In contrast to LT , LT , or LT R gene–targeted mice,
which lack most peripheral lymph nodes, these animals
provide an important opportunity to study the role of
LT R in diabetes pathogenesis in an environment in
which the majority of lymph nodes develop and respond
normally. Thus, it is now possible to discriminate between
developmental and functional effects due to loss of LT R
signaling.
LT R–Fc Expression Does Not Inhibit Insulitis or Sialitis.
Insulitis is an essential step toward type 1 diabetes mellitus
and is characterized by intraislet infiltration of lym-
phocytes that enter via high endothelial venules express-
ing MAdCAM-1 and peripheral lymph node addressin
(PNAd) (14, 15).
To assess if fusion protein expression affects diabetic
processes, a total of 31 mice expressing the antagonist chi-
meric protein (as well as 23 nondiabetic transgene-negative
littermates) were examined at 11, 13, 23, 28, 36, 43, and
52 wk of age for lymphocytic infiltration of islets. As de-
termined by hematoxylin and eosin–stained tissue, neither
insulitis (compare Fig. 2, N and O) nor sialitis (data not
shown) was inhibited by transgene expression in either low
expressing 201 mice or high expressing 1610 mice. As
early as 11 wk of age, lymphocytic infiltration was ob-
served in both islets and salivary glands of control and
LT R–Fc-expressing mice.
To determine whether the fusion protein qualitatively
altered the type of lymphocytic infiltrate, pancreatic tissue
from 12–19-wk-old mice was stained with antibodies spe-
cific for T cell, B cell, macrophage, and dendritic cell sur-
face antigens, as well as for MAdCAM-1, PNAd, vascular
cell adhesion molecule (VCAM)-1, intercellular adhesion
molecule (ICAM)-1, very late antigen (VLA)-4, and l-selec-
tin (MEL-14). No difference was observed between NOD
mice expressing high concentrations of fusion protein and
littermate controls with regard to type and amount of infil-
trate (data not shown).
To determine the extent and severity of islet infiltration,
insulitis was scored from pancreata of 11–13- and 17–19-
wk-old nondiabetic, transgene-positive, and transgene-
negative female littermates. As shown in Fig. 3, transgene-
positive and -negative mice were similar with regard to
level and severity of insulitis. Only minor infiltration was
observed in tissue other than endocrine organs in 6-mo-old
transgene-positive and -negative NOD mice (which occurs
in LT R-deficient mice) (7).
Although fusion protein levels were sufficient to disrupt
splenic lymphoid tissue architecture, pancreatic islet lym-
phocytic infiltration was unaffected. These findings suggest
that this step in the progression toward insulin-dependent
diabetes mellitus (IDDM) is LT R independent or is
quantitatively different from lymphocyte migration within
splenic tissues.
High Concentrations of LT R–Fc Inhibit Diabetes Develop-
ment. To determine the effect of transgene expression on
diabetes development, LT R–Fc-expressing mice were
followed for over 1 yr for glycosuria. As shown in Fig. 4 A,
80% of control transgene-negative female NOD mice de-
veloped diabetes by 25 wk of age. In striking contrast, only
1 of 26 female mice from the high expressing 1610 line de-
veloped diabetes by this age. The low expressing 201
mouse line was also followed for disease onset. IDDM
pathogenesis was inversely related to circulating LT R–Fc
concentrations, as these mice developed somewhat reduced
IDDM compared with littermate controls (which was not
significantly different [P   0.09; Fig. 4 B]).
As shown in Fig. 4 C and described above, LT R–Fc
blocking protein levels declined with age. As LT R–Fc
concentrations fell, the incidence of IDDM began to rise,
so that by 59 wk of age, 47% of the transgene-positive mice
became diabetic (Fig. 4 C). The kinetics of diabetes onset
after the decline in chimeric protein activity closely mir-
rored that of the control group.
These data demonstrate that LT R engagement is a cru-
cial component in diabetic pathogenesis. This was demon-
strated in two ways: first, high expression of fusion protein
inhibited disease onset; second, decline in blocking protein
activity in aged mice was followed by diabetes develop-
ment. We conclude from these experiments that tissue de-
struction characteristic of diabetes requires LT R signaling.
Mice Expressing LT R–Fc Lack Anti-GAD Autoreactive T
Cells. Although mice expressing high concentrations of
LT R–Fc did not begin to develop diabetes until  24 wk
after the control mice, we observed no difference in pan-
Figure 3. LT R blockade does not affect the severity of insulitis. Se-
verity of pancreatic infiltration in high expressing mice (line 1610) or lit-
termate controls was determined in 17–19-wk-old nondiabetic female
mice. Insulitis was classified as: intact islets, periinsulitis, insulitis, or de-
structive insulitis as described in Materials and Methods. A total of 248
islets (average of 62 islets/mouse) from transgene (Tg)-negative animals
and 160 islets (average of 53 islets/mouse) from transgene-positive mice
was scored. Circulating fusion protein concentrations at time of islet
scoring were: #2, 0.47  g/ml; #9, 1.18  g/ml; and #10, 0.53  g/ml.
Data is representative of one of three similar experiments.1338 A Critical Role for Lymphotoxin-  Receptor in Experimental Diabetes
creatic infiltrates between the two groups at early (as well as
late) time points. These data suggest that autoreactive T
cells were present in inflamed tissues but unable to cause
tissue destruction due to loss of LT R signaling.
To test whether autoreactive T cells against islet cell an-
tigens were present, splenocytes were tested for reactivity
to the pancreatic autoantigen, GAD. As shown in Fig. 4,
splenocytes isolated from high expressing 1610 mice dis-
played reduced reactivity toward GAD autoantigen com-
pared with their transgene-negative littermates. Both stim-
ulation indices as well as IFN-  (Fig. 4, D and E) and
IL-10 (data not shown) production in response to GAD
were equivalent to those of C57BL/6 control mice. IL-5
was not detected in any of the cultures (data not shown),
suggesting that the lack of IDDM was not simply due to a
shift from a Th1- to a Th2-type response.
These data suggest that the absence of glycosuria in
LT R–Fc-expressing, 30-wk-old NOD mice was due ei-
ther to a lack of activation of or an absence of autoreactive
T cells specific for the islet cell antigen GAD. However,
these findings do not rule out that T cell reactivity to pan-
creatic autoantigens other than GAD was present in these
mice.
Summary. This study demonstrates that a neutralizing
LT R–Fc fusion protein has the ability to block autoreac-
tive T cell induction of diabetes in NOD mice. The dia-
betic T cell potential remains latent in the presence of high
concentrations of the fusion protein. Remarkably, the dia-
betic process spontaneously activates after the decline of
LT R–Fc fusion protein levels below a critical threshold.
High levels of fusion protein expression are also associated
with disrupted splenic architecture. However, splenic pri-
mary follicles and FDCs formed in aged mice, demonstrat-
ing that the maintenance of splenic structure is a dynamic
process. Possible mechanisms by which LT R–Fc affects
diabetes development include altered T cell localization,
Figure 4. High LT R–Fc expression inhibits diabe-
tes and autoreactive T cell development. Diabetes inci-
dence is shown for female mice expressing (A) high
LT R–Fc levels (line 1610,  ) and littermate controls
( ) or (B) low LT R–Fc levels (line 201,  ) and litter-
mate controls ( ). (C) Diabetes incidence for over one
year ( ), as well as soluble serum fusion protein con-
centrations (light gray squares) are shown for mouse line
1610. Each time point represents the mean and SEM of
circulating fusion protein levels from individual litters of
three to seven mice. In data not shown, monthly serial
blood samples of an individual female 1610 NOD
mouse mirrored the mean serum LT R–Fc concentra-
tions from individual litters. (D) Stimulation index and
(E) IFN-  cytokine production of splenocytes from 12-
wk-old female 1610 NOD mice stimulated with GAD
65. [3H]thymidine incorporation (D) was determined
from triplicate wells of individual mice, and IFN-  (E)
was determined from pooled wells of individual mice.
Mice #15, 16, and 17 were transgene (Tg) negative,
verified by both ELISA and PCR analysis. Soluble
LT R–Fc fusion protein concentration at time of sacri-
fice was: #6, 3.3  g/ml; #7, 1.8  g/ml; #8, 2.0  g/ml,
and #14, 3.5  g/ml. Data in D and E depicts one of
two representative experiments.1339 Ettinger et al. Brief Definitive Report
migration, and/or defective cellular interactions. The re-
sults reported here demonstrate that LT R signaling is re-
quired for progression to autoimmune diabetes.
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